TOKYO–(BUSINESS WIRE)–FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announced that FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for life science research, bioproduction, and cell therapy manufacturing, completed the acquisition of Shenandoah Biotechnology, Inc., a leading manufacturer of recombinant proteins. Terms of the deal were not disclosed.
Located in Warminster, Pennsylvania, Shenandoah Biotechnology manufactures recombinant proteins including cytokines and growth factors. Shenandoah Biotechnology recently launched their CTG Grade� line of cytokines and growth factors that are manufactured according to cGMP guidelines in the Companys new state-of-the-art, ISO 9001:2015 certified facility.
Shenandoah Biotechnologys portfolio of recombinant proteins complements FUJIFILM Irvine Scientific, Inc.s advanced cell culture solutions and expertise in bioprocessing, which will provide customers with a single point of access for their life science research, discovery, and cell and gene therapy needs.
Contacts
Lily Jeffery
Zyme Communications
Phone: +44 (0)7891 477 378
Email: lily.jeffery@zymecommunications.com
UOT Named First Official Importer in Asia for the Award-Winning Blender of Unique, Aged, Cask…
Government of Canada funding for additional engineering and test work to build on and complement…
DUBLIN--(BUSINESS WIRE)--The "Asia-Pacific Pathogen or Plant Disease Detection and Monitoring Market: Focus on Application, Product,…
DUBLIN--(BUSINESS WIRE)--The "Maldives Insurance Industry Market, Key Trends and Opportunities to 2028" report has been…
DUBLIN--(BUSINESS WIRE)--The "Asia-Pacific Electric Vehicle (EV) Charging Communication Unit Market: Focus on Vehicle Type, Propulsion…
SurveyMonkey and Parity find the fandom gap is closing around the world, but women athletes…
